What Are Wall Street Analysts' Target Price for Viatris Stock? [Yahoo! Finance]
Viatris Inc. (VTRS)
Company Research
Source: Yahoo! Finance
America, and the Middle East, delivering a broad portfolio of branded, generic, complex, and biosimilar medicines. Through its four regional segments, the company serves multiple therapeutic areas and distributes its products worldwide via diverse pharmacy and healthcare channels. Shares of the Canonsburg, Pennsylvania-based company have slightly outperformed the broader market over the past 52 weeks. VTRS stock has soared 14.6% over this time frame, while the broader S&P 500 Index ($SPX) has gained 14.3%. Moreover, the stock has returned 5.1% on a YTD basis, compared to SPX's 1.4% rise. Chevron Hikes Its Dividend - But It's Less Than Expected - Is CVX Stock Fully Valued? Before Amazon Invests $50 Billion in OpenAI, How Should You Play AMZN Stock? Commodity Volatility, Earnings and Other Key Things to Watch Stop Missing Market Moves: Get the FREE Barchart Brief – your midday dose of stock movers, trending sectors, and actionable trade ideas, delivered right to your inbox. Si
Show less
Read more
Impact Snapshot
Event Time:
VTRS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VTRS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VTRS alerts
High impacting Viatris Inc. news events
Weekly update
A roundup of the hottest topics
VTRS
News
- Viatris to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026, and Host Investor Event on March 19, 2026PR Newswire
- Mapi Pharma to Present New Safety and Efficacy Data from Glatiramer Acetate Depot Long-Acting Injection Phase II Study in Patients with Primary Progressive Multiple Sclerosis (PPMS) at ACTRIMS Forum 2026 [Yahoo! Finance]Yahoo! Finance
- Viatris Appoints Matthew J. Maletta as Chief Legal Officer [Yahoo! Finance]Yahoo! Finance
- Viatris Appoints Matthew J. Maletta as Chief Legal OfficerPR Newswire
- Davis Opportunity Fund Annual Review 2026 [Seeking Alpha]Seeking Alpha
VTRS
Earnings
- 11/6/25 - Beat
VTRS
Sec Filings
- 2/4/26 - Form SCHEDULE
- 2/3/26 - Form 8-K
- 1/2/26 - Form 4
- VTRS's page on the SEC website